Open Day 1 of ESOC 2025 in Helsinki: OPTIMIST Trial Highlights
European Stroke Organisation (ESO) has shared an insightful post on X:
”Missed it live? Revisit Day 1 PI insights from ESOC 2025 in Helsinki. Investigators, moderated by Jelle De Meester and Teresa Ullberg, discuss the OPTIMIST main trial – nearly 5,000 patients, 114 hospitals, 8 countries.”
Watch the footage here.
Day 1 of ESOC 2025 in Helsinki featured key insights from the highly anticipated OPTIMIST main trial.
The trial was presented by principal investigators and moderated by Jelle De Meester and Teresa Ullberg.
The large-scale trial enrolled nearly 5,000 patients across 114 hospitals in 8 countries, offering robust data on stroke care optimization.
For those who missed the live session, the discussion provided critical updates on trial methodology, patient outcomes, and future directions in acute stroke management.
A must-watch for clinicians and researchers shaping the next generation of stroke care!
Hemostasis Today, your daily source of latest news on stroke management.
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz IrawanÖ‰ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session